After three rejected bids, London-based Unilever is throwing in the towel, stating that it will not raise its $68 billion offer to purchase GSK Consumer Healthcare, the joint venture between GlaxoSmithKline and Pfizer, The Wall Street Journal reported Jan. 19.
Read the full post on Becker's Hospital Review - Healthcare News
